Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man
暂无分享,去创建一个
[1] D. Mangelsdorf,et al. LXRS and FXR: the yin and yang of cholesterol and fat metabolism. , 2006, Annual review of physiology.
[2] J. Auwerx,et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation , 2006, Nature.
[3] Timothy M Willson,et al. Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[4] B. Angelin,et al. Bile acid synthesis in humans has a rapid diurnal variation that is asynchronous with cholesterol synthesis. , 2005, Gastroenterology.
[5] S. Kliewer,et al. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. , 2005, Cell metabolism.
[6] B. Staels,et al. The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism. , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[7] I. Schulman,et al. Regulation of Complement C3 Expression by the Bile Acid Receptor FXR* , 2005, Journal of Biological Chemistry.
[8] G. Salen,et al. Bile acid biosynthesis , 1974, The American Journal of Digestive Diseases.
[9] R. Myers,et al. Modulation of metabolic syndrome by fibroblast growth factor 19 (FGF19)? , 2004, Endocrinology.
[10] S. Kliewer,et al. Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis. , 2003, Genes & development.
[11] B. Angelin,et al. Monitoring hepatic cholesterol 7α-hydroxylase activity by assay of the stable bile acid intermediate 7α-hydroxy-4-cholesten-3-one in peripheral blood Published, JLR Papers in Press, January 16, 2003. DOI 10.1194/jlr.D200043-JLR200 , 2003, Journal of Lipid Research.
[12] B. Angelin,et al. Monitoring hepatic cholesterol 7alpha-hydroxylase activity by assay of the stable bile acid intermediate 7alpha-hydroxy-4-cholesten-3-one in peripheral blood. , 2003, Journal of lipid research.
[13] D. Russell,et al. Loss of nuclear receptor SHP impairs but does not eliminate negative feedback regulation of bile acid synthesis. , 2002, Developmental cell.
[14] M. Karin,et al. Redundant pathways for negative feedback regulation of bile acid production. , 2002, Developmental cell.
[15] D. French,et al. Printed in U.S.A. Copyright © 2002 by The Endocrine Society Transgenic Mice Expressing Human Fibroblast Growth Factor-19 Display Increased Metabolic Rate and Decreased Adiposity , 2022 .
[16] T. A. Kerr,et al. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. , 2000, Molecular cell.
[17] L. Moore,et al. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. , 2000, Molecular cell.
[18] C. Deng,et al. Elevated Cholesterol Metabolism and Bile Acid Synthesis in Mice Lacking Membrane Tyrosine Kinase Receptor FGFR4* , 2000, The Journal of Biological Chemistry.
[19] A. Goddard,et al. FGF-19, a novel fibroblast growth factor with unique specificity for FGFR4. , 1999, Cytokine.
[20] M. Makishima,et al. Identification of a nuclear receptor for bile acids. , 1999, Science.
[21] N. Itoh,et al. Structure and expression of a novel human FGF, FGF-19, expressed in the fetal brain. , 1999, Biochimica et biophysica acta.
[22] S. Hughes,et al. Differential Expression of the Fibroblast Growth Factor Receptor (FGFR) Multigene Family in Normal Human Adult Tissues , 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[23] J. Chiang,et al. Identification and characterization of a putative bile acid-responsive element in cholesterol 7 alpha-hydroxylase gene promoter. , 1994, The Journal of biological chemistry.
[24] K. Einarsson,et al. Bile acid synthesis in humans: regulation of hepatic microsomal cholesterol 7 alpha-hydroxylase activity. , 1989, Gastroenterology.
[25] K. Einarsson,et al. Hepatic uptake of bile acids in man. Fasting and postprandial concentrations of individual bile acids in portal venous and systemic blood serum. , 1982, The Journal of clinical investigation.
[26] K. Einarsson,et al. Effects of cholestyramine and chenodeoxycholic acid on the metabolism of endogenous triglyceride in hyperlipoproteinemia. , 1978, Journal of lipid research.